Literature DB >> 12631112

Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.

Sho-Ichi Yamagishi1, Yosuke Inagaki, Tamami Okamoto, Shinjiro Amano, Kohachiro Koga, Masayoshi Takeuchi.   

Abstract

BACKGROUND: We have shown previously that OPB-9195, a novel inhibitor of advanced glycation end products (AGE), significantly prevented renal tubular injury and tubulointerstitial fibrosis in spontaneous diabetic rats. However, the molecular mechanisms underlying this have not been fully elucidated.
METHODS: Three immunochemically distinct AGE were prepared by incubating bovine serum albumin (BSA) with glucose, glyceraldehyde, or methylglyoxal. Then, the effects of AGE on human proximal tubular epithelial cells were examined. The intracellular formation of reactive oxygen species (ROS) was detected using the fluorescent probe CM-H2DCFDA. DNA synthesis was evaluated by thymidine uptake, and de novo protein synthesis was determined by [3H]leucine incorporation. Prostaglandin E2 (PGE2) and transforming growth factor-beta (TGF-beta) released into media were quantitatively analyzed in an enzyme-linked immunosorbent assay. TGF-beta gene expression was analyzed by quantitative reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: When these AGE-BSA were administered to tubular cells, each of them increased generation of intracellular ROS. All of the AGE-BSA, but not non-glycated BSA, were found to induce statistically significant decreases in de novo protein synthesis and PGE2 secretion by tubular cells. Furthermore, AGE-BSA up-regulated the levels of mRNAs for TGF-beta in tubular cells. The structural epitope designated glucose-derived AGE was found to have the greatest cytopathic effects on tubular cells. These AGE-induced inhibition of protein synthesis and PGE2 secretion as well as the up-regulation of TGF-beta mRNA were found to be completely prevented by N-acetylcysteine. Furthermore, H2O2 was shown to inhibit protein synthesis and PGE2 secretion by proximal tubular cells in a dose-dependent manner.
CONCLUSION: The results suggest that AGE inhibits de novo protein synthesis and stimulates TGF-beta mRNA expression in proximal tubular epithelial cells through overgeneration of intracellular ROS. Thus, AGE are involved in the pathogenesis of tubular injury in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631112     DOI: 10.1046/j.1523-1755.2003.00752.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

Review 1.  Trends in advanced glycation end products research in diabetes mellitus and its complications.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-03-23       Impact factor: 3.396

Review 2.  The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.

Authors:  Stephen P Gray; Karin Jandeleit-Dahm
Journal:  J Mol Med (Berl)       Date:  2014-04-01       Impact factor: 4.599

3.  Novel role of NF-κB-p65 in antioxidant homeostasis in human kidney-2 cells.

Authors:  Liza E George; Mustafa F Lokhandwala; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-07

4.  Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury.

Authors:  Li Wang; Chun-jiang Yu; Wei Liu; Lu-yang Cheng; Yi-na Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-07-18       Impact factor: 6.150

5.  Advanced glycation end products and diabetic nephropathy: a comparative study using diabetic and normal rats with methylglyoxal-induced glycation.

Authors:  Lisa Rodrigues; Paulo Matafome; Joana Crisóstomo; Daniela Santos-Silva; Cristina Sena; Paulo Pereira; Raquel Seiça
Journal:  J Physiol Biochem       Date:  2013-09-28       Impact factor: 4.158

6.  Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.

Authors:  Arthur C K Chung; Haiyan Zhang; Yao-Zhong Kong; Jia-Ju Tan; Xiao R Huang; Jeffrey B Kopp; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

Review 7.  Advanced glycation end products, oxidative stress and diabetic nephropathy.

Authors:  Sho-Ichi Yamagishi; Takanori Matsui
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

8.  Effects of N-hexacosanol on nitric oxide synthase system in diabetic rat nephropathy.

Authors:  Shinichi Okada; Motoaki Saito; Emi Kazuyama; Takuya Hanada; Yasuo Kawaba; Atsushi Hayashi; Keisuke Satoh; Susumu Kanzaki
Journal:  Mol Cell Biochem       Date:  2008-06-05       Impact factor: 3.396

Review 9.  Heme oxygenase-1 as a target for TGF-β in kidney disease.

Authors:  Abolfazl Zarjou; Anupam Agarwal
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

Review 10.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.